Ashour S. Ahmed
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 17, 2024
mTOR-mediated p62/SQSTM1 stabilization confers a robust survival mechanism for ovarian cancer.
Journal: Cancer letters
Published: November 22, 2024
3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline.
Journal: Advanced healthcare materials
Published: October 19, 2024
The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre.
Journal: Translational cancer research
Published: January 12, 2024
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre.
Journal: Translational cancer research
Published: May 19, 2023
Single-cell transcriptomics identifies a WNT7A-FZD5 signaling axis that maintains fallopian tube stem cells in patient-derived organoids.
Journal: Cell reports
Published: April 04, 2023
Investigation of the Potential Mechanisms Underlying Nuclear F-Actin Organization in Ovarian Cancer Cells by High-Throughput Screening in Combination With Deep Learning.
Journal: Frontiers in cell and developmental biology
Published: February 04, 2022
Studying Müllerian duct anomalies - from cataloguing phenotypes to discovering causation.
Journal: Disease models & mechanisms
Published: June 23, 2021
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer.
Journal: Cancer research
Published: May 11, 2021
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.
Journal: JCI insight
Published: January 25, 2021
Last Updated: 09/26/2026